NeuroMetrix, Inc.

NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. NeuroMetrix markets the following products: DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com. NeuroMetrix, Inc. is a wholly-owned subsidiary of electroCore, Inc. While operating under the ownership of electroCore, NeuroMetrix will continue to provide its Quell products and services under its established brand. Our Terms of Service and Privacy Policy have been updated to reflect this change. Please review these updates to understand how this new relationship may affect your experience with us. If you have any questions, please contact us at 888-903-2673.